Cresco Labs FY2025 EPS Forecast Reduced by Ventum Cap Mkts

Cresco Labs Inc. (OTCMKTS:CRLBF) – Research analysts at Ventum Cap Mkts dropped their FY2025 earnings estimates for Cresco Labs in a report issued on Wednesday, March 12th. Ventum Cap Mkts analyst A. Semple now expects that the company will post earnings per share of ($0.09) for the year, down from their prior forecast of ($0.08). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share.

Cresco Labs (OTCMKTS:CRLBF) last announced its quarterly earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The firm had revenue of $176.00 million during the quarter, compared to analysts’ expectations of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%.

A number of other research analysts have also recently issued reports on the stock. Atb Cap Markets cut shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Cormark upgraded shares of Cresco Labs from a “hold” rating to a “moderate buy” rating in a research note on Monday. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Cresco Labs has a consensus rating of “Buy” and an average price target of $3.00.

Cresco Labs Stock Down 4.0 %

Shares of CRLBF opened at $0.71 on Monday. The stock has a market cap of $344.14 million, a price-to-earnings ratio of -3.53 and a beta of 1.79. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. Cresco Labs has a 12 month low of $0.70 and a 12 month high of $2.60. The company has a 50-day moving average price of $0.88 and a two-hundred day moving average price of $1.19.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.